KRAS and colorectal carcinoma: KRAS mutations are prevalent in several cancers such as PDAC, NSCLC, and CRC; and the G12, G13, and Q61 positions are frequently mutated hotspots (Burge and Hobbs, 2022; Luo et al., 2024).